Volume 29, Supplement 1

PRESENTATION

GERAL

1 – REDUCTION IN OVERALL SURVIVAL OF WOMEN WITH METASTATIC BREAST CANCER IN LOW- AND MIDDLE-INCOME COUNTRIES: A REFLECTION OF LACK OF ACCESS?

3 – LEAN MASS IS INVERSELY ASSOCIATED WITH BREAST CANCER, WHILE ABDOMINAL ADIPOSITY AND INSULIN RESISTANCE INCREASES THE CHANCES OF DEVELOPING THE CANCER.

4 – ANALYSIS OF CLINICAL OUTCOMES BASED ON MOLECULAR SUBTYPES IN PATIENTS WITH BREAST CANCER THAT RECEIVED NEOADJUVANT CHEMOTHERAPY

5 – TUMOR MUTATIONAL BURDEN (TMB) IS A POTENTIAL PREDICTOR OF RESPONSE TO IMMUNE CHECKPOINT INHIBITORS (ICI) IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MTNBC) .

6 – ONCOTYPE DX® IN THE SISTEMA ÚNICO DE SAÚDE DO BRASIL (SUS): RESULT OF 125 CASES

7 – FUNCTIONAL AND PROGNOSTIC ANALYSIS OF AGR2 (ANTERIOR GRADIENT PROTEIN 2) IN BREAST CANCER USING IN-SILIC DATA

8 – COMPARATIVE EFFECTIVENESS OF BREAST CONSERVING SURGERY VERSUS MASTECTOMY ON SURVIVAL IN BREAST CANCER PATIENTS THAT RECEIVED NEOADJUVANT CHEMOTHERAPY AND POST-OPERATIVE RADIATION THERAPY

9 – INFLUENCE OF THE SURGICAL CLIP ON BREAST, HEART AND LUNG VOLUMES OF PATIENTS SUBMITTED TO BOOST DURING THE PLANNING OF BREAST CANCER RADIOTHERAPY, ACCORDING TO ONCOPLASTIC SURGERY
10 – ONCOPLASTIC SURGERY IN BREASTCONSERVATIVE TREATMENT: PATIENT PROFILE AND IMPACT ON QUALITY OF LIFE

11 – COSMETIC OUTCOMES IN BREAST ONCOPLASTY: RETROSPECTIVE COHORT TO COMPARE OBJECTIVE AND SUBJECTIVE METHODS OF EVALUATION

12 – REGIONAL DIFERENCES OF BREAST CANCER RECONSTRUCTIVE SURGERIES AMONG BRAZIL´S PUBLIC HEALTHCARE USERS: A 10 YEAR STUDY

13 – ONCOPLASTIC MAMMAPLASTY WITH GEOMETRIC COMPENSATION – OUTCOMES AND FOLLOW-UP OF A MULTICENTRIC PROSPECTIVE COHORT

14 – LIRAGLUTIDE AS A NOVEL DNA DEMETHYLATING AGENT AND ITS POTENTIAL USE IN THE ADJUVANT TREATMENT OF HIGLY INVASIVE BREAST CANCER

15 – FACTORS ASSOCIATED WITH RETURN TO WORK OF BREAST CANCER SURVIVORS TREATED AT THE PUBLIC CANCER HOSPITAL IN BRAZIL

16 – RECIST EVALUATION OF THE USE OF SALVAGE RADIOTHERAPY IN LOCALLY ADVANCED BREAST CANCER REFRACTORY TO NEOADJUVANT CHEMOTHERAPY AND UNRESECTABLE

COMMENTED POSTER

17 – INFLUENCE OF LIFESTYLE FACTORS ON BREAST CANCER RISK: A CASE-CONTROL STUDY WITH A REPRESENTATIVE SAMPLE OF THE BRAZILIAN POPULATION

18 – TRENDS IN THE INCIDENCE OF BREAST CANCER FOLLOWING THE RADIOLOGICAL ACCIDENT IN GOIÂNIA: A 25-YEAR ANALYSIS

19 – AXILLARY SURGICAL APPROACH IN METASTATIC BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS

20 – GEOMETRIC COMPENSATION TECHNIQUE FOR BREAST CONSERVATIVE TREATMENT: EXPANDING THE INDICATIONS AND COSMETIC EVALUATION

21 – FIRST STUDY OF THE PREVALENCE OF THE TP53 P.R337H MUTATION IN BREAST CANCER PATIENTS IN THE CENTRAL REGION OF BRAZIL

22 – REAL WORLD DATA ON PATIENT PROFILES AND PATTERNS OF CARE IN DE NOVO METASTATIC BREAST CANCER: AN ANALYSIS OF 17 YEARS (1995–2011)

23 – OVERALL SURVIVAL INCREASE AFTER TREATMENT OF BRAIN METASTASIS FOR HER-2 POSITIVE PATIENTS USING TRASTUZUMAB

24 – EFFECT OF NUTRITIONAL STATUS ON HEALTHRELATED QUALITY OF LIFE (HRQL) THROUGHOUT CHEMOTHERAPY: A PROSPECTIVE STUDY

25 – ANALYSIS OF EPIGENETIC MOLECULES SIRT2 E SIRT6 IN BREAST CANCER SUBTYPES

26 – PLASMA BIOMARKERS OF SYSTEMIC REDOX STATUS: A POTENTIAL PREDITOR OF CHEMOTHERAPY. EFFICACY IN WOMEN WITH BREAST CANCER

27 – ATTENUATED TOTAL REFLECTION-FOURIER TRANSFORM INFRARED (ATR-FTIR) SPECTROSCOPY ANALYSIS OF SALIVA FOR BREAST CANCER DIAGNOSIS

28 – COMPARISON OF THE ANTIPROLIFERATIVE ACTIVITY OF DIFFERENT EXTRACTS FROM POTHOMORPHE UMBELLATA IN BREAST CANCER CELL LINES

29 – POTENTIAL APPLICATION OF A SEROLOGICAL SPECTRAL BIOMARKER FOR ALTERNATIVE DIAGNOSIS OF BREAST CANCER

30 – REGIONAL DIFERENCES OF BREAST CANCER SURGERIES AMONG BRAZIL´S PUBLIC HELTHCARE USERS: A 10-YEAR STUDY

31 – INVASIVE APPROACHES IN BENIGN BREAST TUMORS IN BRAZIL

E-POSTER

32 – TELOMERASE POLYMORPHISM AND BREAST CANCER

33 – BARRIERS RELATED TO MAMMOGRAPHY IN THE RIVERSIDE POPULATION OF THE BRAZILIAN AMAZON: CASE-CONTROL STUDY

34 – BRINGING PATIENT NAVIGATION TO PRIMARY HEALTH CARE IN RIO DE JANEIRO: PILOT PROJECT IN THE ANDARAÍ COMMUNITY

35 – PREDICTION OF ATTENDANCE TO THE “60 DAYS LAW” WITHIN THE PATIENT NAVIGATION PROGRAM TO BREAST CANCER IN RIO DE JANEIRO

36 – STRATEGIES OF GUIDELINES IMPLEMENTATION FOR THE BREAST CANCER EARLY DETECTION IN BRAZIL

37 – SEXUAL DYSFUNCTION AMONG WOMEN WITH BREAST CANCER DIAGNOSTIC: DESCRIPTIVE STUDY

38 – MICRO-RNA 21 ACTING AS AN ONCOMIR ON HER2 POSITIVE BREAST CANCER: A META-ANALYSIS

39 – BREAST CANCER SURVIVAL: A HOSPITAL REGISTRY-BASED RETROSPECTIVE COHORT OF SÃO PAULO, BRAZIL

40 – IS SENTINEL LYMPH NODE BIOPSY SAFE FOR T3 AND T4 BREAST TUMORS? ANALYSIS OF A INSTITUTIONAL CASE SERIES AND SYSTEMATIC LITERATURE REVIEW

41 – STANDARD BREAST-CONSERVING VERSUS ONCOPLASTIC SURGERY: A LOCOREGIONAL RECURRENCE COMPARISON

42 – FIRST BRAZILIAN EXPERIENCE WITH VACUUMASSISTED BREAST BIOPSIES GUIDED BY PRONE TOMOSYNTHESIS: 197 CASES

43 – HIGHER PRO-INFLAMMATORY DIET AND WORSE NUTRITIONAL STATUS DURING CHEMOTHERAPY: A PROSPECTIVE STUDY WITH BREAST CANCER WOMEN

44 – EATING LATE AND LESS FREQUENTLY HAS A NEGATIVE IMPACT ON THE DIET QUALITY OF BREAST CANCER WOMEN UNDERGOING ENDOCRINE THERAPY

45 – BILATERAL BREAST RECONSTRUCTION SURGERY: ECONOMIC PERSPECTIVES AND IMPLICATIONS ON THE QUALITY OF LIFE OF PATIENTS SUBMITTED TO UNILATERAL BREAST CANCER MASTECTOMY

46 – QUALITY OF LIFE AND AESTHETIC SATISFACTION OF BREAST CANCER PATIENTS SUBMITTED TO NEOADJUVANT CHEMOTHERAPY AND SURGERY WITH OR WITHOUT IMMEDIATE RECONSTRUCTION

47 – ANALYSIS OF THE PREVALENCE OF THE C.156_157INSALU PATHOGENIC VARIANT IN BRCA2 GENE IN CENTRAL BRAZIL PATIENTS WITH SUSPECTED HEREDITARY BREAST AND OVARY CANCER SYNDROME (HBOC)

48 – INSTRUCTION LEVEL AND SKIN COLOR EXPRESSED IN MAMMOGRAMS IN THE STATE OF GOIÁS IN 2013

49 – CLINICAL AND MOLECULAR EVALUATION OF MICROCALCIFICATIONS CLASSIFIED AS BIRADS® 4 AND 5

50 – PATIENTS WITH BREAST CANCER: CHANGES IN BODY IMAGE

51 – PREVALENCE OF TP53 P.R337H MUTATION IN BRAZILIAN BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW OF THE LITERATURE

52 – THE EARLY DETECTION OF BREAST CANCER THROUGH SELF-EXAMINATION IN THE BASIC HEALTH CARE IN GOING FROM GOIANIA BETWEEN 2017/2–2018/1

53 – PRODUCTION OF LIPID-CORE NANOCAPSULES CONTAINING LYCOPENE-RICH EXTRACT FROM RED GUAVA (PSIDIUM GUAJAVA L.) WITH CYTOTOXIC ACTIVITY IN BREAST CANCER CELLS

54 – EPIDEMIOLOGICAL REVIEW OF SURGICAL PROCEDURES PERFORMED IN MALIGNANT HISTOPATHOLOGICAL FINDINGS IN BRASÍLIA, CAPITAL OF BRAZIL

55 – CASES OF BREAST CANCER IN GOIÁS BETWEEN SEPTEMBER 2009 AND FEBRUARY 2014 DIAGNOSED FROM ANATOMOPATHOLOGICAL EXAMINATION

56 – COMPARING CONVENTIONAL BREAST CONSERVING SURGERY WITH THE MINIMALLY INVASIVE APPROACH TECHNIQUE TO TREAT EARLY BREAST CANCER – A RETROSPECTIVE CASE CONTROL STUDY

57 – IMPACT OF REFERENCE CENTER ON BREAST CANCER IN CAPITAL CITY

58 – EVALUATION OF METASTATIC STAGE PATIENT CHARACTERISTICS ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE

59 – PROGNOSTIC EVALUATION OF PATIENTS WITH LUMINAL B IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FROM 2006 TO 2014

60 – PROGNOSTIC EVALUATION OF PATIENTS WITH TRIPLE NEGATIVE IMMUNOPHENOTYPE, SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT THE ONCOGINECOLOGY AND MASTOLOGY SERVICE OF DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE

61 – DUCTAL CARCINOMA IN SITU OF THE BREAST: FIRST ANALYSIS OF 167 CASES

62 – COULD PRIMARY TUMOR RESECTION IMPROVE SURVIVAL IN METASTATIC BREAST CANCER?

63 – THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY AND BREAST CANCER: PREVENTION, TREATMENT AND RECONSTRUCTION OF SELF-ESTEEM

64 – ACCESSIBILITY TO BREAST CANCER TREATMENT AND BARRIERS TO HEALTH ASSISTANCE

65 – THE IMPORTANCE OF EARLY DETECTION OF DEPRESSION IN POST-MASTECTOMY PATIENTS

66 – EXPOSURE TO ENDOCRINE DISPERSERS AND XENOESTROGEN IN THE DEVELOPMENT OF BREAST CANCER: A LITERATURE REVIEW

67 – IMPLICATIONS OF ALTERNATIVE TREATMENT IN BREAST CANCER

68 – ELASTOGRAPHY: THE IMPACT OF THE USE OF THE TOOL FOR THE CHARACTERIZATION OF BREAST LESIONS

69 – IMPACT OF SILICONE IMPLANT OR SALINE EXPANDER AND CONTRALATERAL SYMMETRIZATION IN QUALITY OF LIFE OF PATIENTS SUBMITTED TO IMMEDIATE RECONSTRUCTION

70 – IMPORTANCE OF THE TRIPLE TEST AND FREQUENCY OF BREAST CANCER IN WOMEN SUBMITTED TO THE EXEMPTION OF BREAST NODE

71 – MOLECULAR PROFILE AND PATHOLOGICAL RESPONSE AFTER NEOADJUVANT CHEMOTHERAPY IN PATIENTS UNDERGOING SURGERY FOR BREAST CANCER IN THE MASTOLOGY UNIT OF THE HOSPITAL DE BASE DO DISTRITO FEDERAL BETWEEN 2014 AND 2016

72 – HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF 22 CASES OF MALE BREAST CANCER

73 – PROFILE OF LOCOREGIONAL RECURRENCE AND DISTANT METASTASIS OF BREAST CANCER IN BRAZILIAN WOMEN

74 – PROFESSIONAL APPROACH ON WOMEN WITH BREAST CANCER: A LEARNING PROCESS

75 – AVALIAÇÃO CLINICA E CIRÚRGICA DE GINECOMASTIA EM PACIENTES DO SUS

76 – THE IMPACT OF A HIGHER EATING FREQUENCY ON THE QUALITY OF DIET AND NUTRITIONAL STATUS OF BREAST CANCER WOMEN UNDERGOING CHEMOTHERAPY

77 – EVALUATION OF PATIENTS WITH INVASIVE BREAST CARCINOMA SUBMITTED TO NEOADJUVANT CHEMOTHERAPY ATTENDED AT DR ARNALDO VIEIRA DE CARVALHO CANCER INSTITUTE FORM 2006 TO 2014

78 – MONITORING OF RISK FACTORS IN FAMILY MEMBERS OF PATIENTS WITH BREAST CANCER

79 – IMPORTANCE OF HEALTH AGENTS IN THE PREVENTION OF BREAST CANCER

80 – THE IMPORTANCE OF SOCIAL SUPPORT AS A DRIVER OF IMPROVEMENT IN THE TREATMENT OF BREAST CANCER

81 – LITERATURE REVIEW: PSYCHIATRY IN PATIENTS WITH BREAST CANCER

82 – MAMMOGRAPHY AND BREAST CANCER: ANALYSIS OF A PROVEN SCREENING METHOD

83 – THE IMPORTANCE OF EXERCISE IN THE PREVENTION OF BREAST CANCER

84 – UNILATERAL PAGET’S DISEASE IN YOUNG ADULT: A CASE REPORT

85 – NURSING ASSISTANCE TO PATIENTS WITH BREAST CANCER

86 – NURSING ASSISTANCE IN THE TREATMENT OF BREAST CANCER TO VULNERABILITIES AND CHALLENGES

87 – THE COUNSEL OF BREAST CANCER IN THE FAMILY HEALTH STRATEGY

88 – THE RELATIONSHIP BETWEEN THE CONSUPTION OF ISOFLAVONES AND THE DEVELOPMENT OF BREAST CANCER

89 – VEGETARIAN DIET AND BREAST CANCER RISK: WHAT IS THE RELATION?

90 – POST-OPERATIVE OUTCOME IN ELECTIVE SURGERIES

91 – PREVENTIVE AND EDUCATIONAL PERFORMANCE OF THE BREAST LEAGUE IN THE MEETING OF ACADEMIC LEAGUES (ELA)

92 – BREAST CANCER AND YOUR RELATION WITH SEXUAL HORMONES

93 – BRCA2 C.156_157 INSALU MUTATION IN A MALE BRAZILIAN PATIENT WITH BREAST CANCER

94 – OCULAR AND ORBITAL METASTASIS IN BREAST CANCER: CASE SERIES REPORT

95 – UNUSUAL METASTASIS OF BREAST CANCER: REPORT OF THREE CASES

96 – BENIGN BREAST LUMPS: SYSTEMATIC REVIEW OF DIAGNOSIS AND CONDUCT

97 – PATIENT PROFILE WITH EARLY STAGE BREAST CANCER SUBMITTED TO INTRAOPERATIVE RADIOTHERAPY IN TERTIARY SERVICE IN GOIÂNIA

I – Volume 29, Supplement 1, 2019

See full edition